ARCT
Price
$26.51
Change
+$0.34 (+1.30%)
Updated
Apr 26, 1:19 PM EST
10 days until earnings call
BNTX
Price
$87.42
Change
+$0.71 (+0.82%)
Updated
Apr 26, 1:24 PM EST
10 days until earnings call
Ad is loading...

Analysis and predictions ARCT vs BNTX

Header iconARCT vs BNTX Comparison
Open Charts ARCT vs BNTXBanner chart's image
Arcturus Therapeutics Holdings
Price$26.51
Change+$0.34 (+1.30%)
Volume$417
CapitalizationN/A
BioNTech SE American Depositary Share
Price$87.42
Change+$0.71 (+0.82%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
ARCT vs BNTX Comparison Chart

Loading...

ARCTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BNTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ARCT vs. BNTX commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a StrongSell and BNTX is a Hold.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (ARCT: $26.17 vs. BNTX: $86.71)
Brand notoriety: ARCT and BNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 102% vs. BNTX: 70%
Market capitalization -- ARCT: $704.37M vs. BNTX: $20.9B
ARCT [@Biotechnology] is valued at $704.37M. BNTX’s [@Biotechnology] market capitalization is $20.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $562.44B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileBNTX’s FA Score has 2 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • BNTX’s FA Score: 2 green, 3 red.
According to our system of comparison, BNTX is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 4 TA indicator(s) are bullish while BNTX’s TA Score has 4 bullish TA indicator(s).

  • ARCT’s TA Score: 4 bullish, 3 bearish.
  • BNTX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than ARCT.

Price Growth

ARCT (@Biotechnology) experienced а -0.57% price change this week, while BNTX (@Biotechnology) price change was +0.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.00%. For the same industry, the average monthly price growth was -2.94%, and the average quarterly price growth was +1264.32%.

Reported Earning Dates

ARCT is expected to report earnings on May 06, 2024.

BNTX is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+8.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ARCT with price predictions.
OPEN
A.I.dvisor published
a Summary for BNTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BNTX($20.9B) has a higher market cap than ARCT($704M). ARCT (-17.000) and BNTX (-17.842) have similar YTD gains .
ARCTBNTXARCT / BNTX
Capitalization704M20.9B3%
EBITDAN/AN/A-
Gain YTD-17.000-17.84295%
P/E RatioN/A21.15-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTBNTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ARCTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BNTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGKRX23.030.16
+0.70%
PGIM Jennison Technology R6
MDISX31.53-0.11
-0.35%
Franklin Mutual Global Discovery Z
GRSRX48.74-0.19
-0.39%
Cohen & Steers Global Realty R
NAINX10.74-0.06
-0.56%
Virtus Tactical Allocation A
MDVNX12.20-0.08
-0.65%
MassMutual Diversified Value R3

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
-3.00%
AXON - ARCT
49%
Loosely correlated
+1.27%
ORMP - ARCT
45%
Loosely correlated
-2.95%
VCYT - ARCT
42%
Loosely correlated
-2.11%
BEAM - ARCT
42%
Loosely correlated
-5.01%
SNDX - ARCT
42%
Loosely correlated
-1.06%
More

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-1.57%
MRNA - BNTX
65%
Loosely correlated
-2.45%
AXON - BNTX
43%
Loosely correlated
+1.27%
NGM - BNTX
36%
Loosely correlated
N/A
FGEN - BNTX
33%
Loosely correlated
+3.63%
CDXS - BNTX
33%
Loosely correlated
-5.36%
More